March 20, 2020
CRISPR technology is a rapidly growing component of the genetics industry. Here's what investors need to know about its future...
November 24, 2019
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
November 19, 2019
This is the first time CRISPR/Cas9 gene-editing technology has been used in human trials to treat genetic diseases.
July 2, 2019
For investors looking for less volatility compared to stocks, here's an overview of the five largest biotechnology ETFs for consideration.
February 25, 2019
CRISPR Therapeutics (NASDAQ:CRSP) has announced financial results for its fourth quarter and full year ended December 31, 2018. As quoted...
November 13, 2018
CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
October 11, 2018
CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Vertex Pharmaceuticals (NASDAQ:VRTX) today announced...